Quantitative Analysis of Metastatic Lymph Nodes after Curative Surgery in Gastric Cancer.
- Author:
Wansik YU
1
;
Yeon Sik JI
;
Gyu Seok CHOI
;
Ilwoo WHANG
;
In Soo SUH
Author Information
1. Department of Surgery, Kyungpook National University Hospital, Taegu, Korea.
- Publication Type:Original Article
- Keywords:
Staging of cancer;
Lymphadenectomy;
Frequency of lymph node metastasis
- MeSH:
Follow-Up Studies;
Gastrectomy;
Humans;
Lymph Node Excision;
Lymph Nodes*;
Neoplasm Metastasis;
Prognosis;
Stomach Neoplasms*;
Survival Rate
- From:Journal of the Korean Cancer Association
1997;29(1):62-68
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: A consecutive series of 710 patients who underwent curative gastrectomy for carcinoma was studied with a special reference to the number or frequency of lymph node metastasis and the patient's prognosis. MATERIAL AND METHODS: Survival rates were calculated by the Kaplan-Meier method, and the difference between each group was evaluated statistically by the log-rank method. Follow-up was obtained for 709 patients (99.9%). RESULTS: According to the number of lymph nodal metastases, the five year survival rate for group 1 (1~3 positive nodes) was 50.9%; for group 2 (4~6 positive nodes), 56.7%; and for group 3 (more than 6 positive nodes), 12.0% (p<0.0001). According to the frequency of lymph node metastases, the five year survival rate for those with up to 25 per cent frequency of metastases was 47.5%; for those with up to 50 per cent frequency of metastases, 15.6%; and for those with greater than 50 per cent metastases, 6.3% (p<0.0001). According to the frequency of the regional lymph nodes (which include perigastric nodes along the lesser and greater curvatures, nodes located along the left gastric, common hepatic, splenic, and celiac arteries) metastasis, we categorized them as group 0 (N0: no metastasis), 1 (N1: metastasis in up to 25%), and 2 (N2: metastasis in greater than 25%). CONCLUSION: This subdivision could be successfully applied to the clinical evaluation of gastric carcinoma (five year survival rate for N0, 86.9%; for N1, 49.0%; and for N2, 10.7% (p<0.0001)) without difficulty in dividing certain lymph nodes into the correct location.
